Skip to main content

Table 3 Patient (a) socio-demographic and (b) clinical characteristic

From: Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective

 

Frequency (%)

(a) Description of socio-demographic variables (N = 574)

Region, n (%)

Central

160 (27.9)

Southern

80 (13.9)

Northern

72 (12.5)

East Coast

156 (27.2)

East Malaysia

106 (18.5)

Female patient, n (%)

317 (55.2)

Age

Mean (SD)

17.3 (10.6)

Median (IQR)

15 (15)

Age group of patient, n (%)

Less than 18 years old

347 (60.5)

18 years old and above

227 (39.5)

Weight (kg)

Mean (SD)

36.8 (16.1)

Ethnic, n (%)

Malay

391 (68.1)

Chinese

95 (16.6)

Indian

3 (0.5)

KadazanDusun

59 (10.3)

Bajau

9 (1.6)

Other-Sabahan native

2 (0.3)

Others

15 (2.6)

Working/schooling status at enrolment, n (%)

Less than 18 years old (n = 347)

 

Not schooling

35 (10.1)

Student

310 (89.3)

Not recorded

2 (0.6)

18 years old and above (n = 227)

 

Student

36 (15.9)

Adult—working

130 (57.3)

Adult—not working

61 (26.9)

(b) Description of clinical characteristic

 

Age at First transfusion as TDT

Mode (Min, Max)

1 (0, 50)

Years of transfusion

Mean, SD

13.4 (8.9)

Presence of IOL complications, n (%)

Yes

255 (44.6)

No

319 (55.4)

Types of current ICT, n (%)

Desferrioxamine(DFO)

67 (11.7)

Deferrasirox (DFX)

238 (41.5)

Deferiprone (DFP)

70 (12.2)

DFO + DFP

154 (26.8)

DFO + DFX

32 (5.6)

DFX + DFP

12 (2.1)

DFO + DFP + DFX

1 (0.2)